Stephen Ma
Direttore Finanziario/CFO presso SCILEX HOLDING COMPANY
Patrimonio netto: 15 271 $ in data 31/05/2024
Profilo
Stephen Ma is currently working as the Secretary, Chief Financial Officer & Senior VP at Scilex Holding Co. He previously worked as the Director-Finance & Operations at Anwita Biosciences, Inc. Mr. Ma has an undergraduate and graduate degree from San Jose State University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SCILEX HOLDING COMPANY
0.01% | 17/05/2024 | 14 140 ( 0.01% ) | 15 271 $ | 31/05/2024 |
Posizioni attive di Stephen Ma
Società | Posizione | Inizio |
---|---|---|
SCILEX HOLDING COMPANY | Direttore Finanziario/CFO | 22/09/2023 |
Precedenti posizioni note di Stephen Ma
Società | Posizione | Fine |
---|---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Direttore Finanziario/CFO | 01/01/2022 |
Formazione di Stephen Ma
San Jose State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SCILEX HOLDING COMPANY | Health Technology |
Aziende private | 1 |
---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Health Technology |
- Borsa valori
- Insiders
- Stephen Ma